Researchers have identified metabolic vulnerabilities in Fibrolamellar cancer, a rare liver malignancy affecting adolescents and young adults, using functional profiling and mass spectrometry. The ...

An AI-assisted drug discovery platform using transfer learning has identified a promising gp130 inhibitor for colorectal ...

German researchers have used cerebral organoids to investigate how the epilepsy medication valproate interferes with early ...

Researchers have developed a scalable bioreactor-based system to produce cardiac organoids that successfully integrated into ...

NIH researchers have identified the intracellular signalling pathways through which semaglutide and other GLP-1 receptor agonists induce weight loss, revealing why patient responses vary and treatment ...

A novel 3D-printed confined culture system has enabled researchers to generate larger, more advanced human gastrointestinal ...

Genome-wide association studies have linked thousands of genetic variants to disease, yet most remain disconnected from drug-relevant biology. Neville Sanjana, Professor at New York University and ...

Based Models is calling for greater flexibilty from the FDA to accomodate rapidly changing technologies like stem ...

At AACR 2026, industry leaders discussed how oncology R&D is moving beyond isolated technological advances towards integrated ...

Despite rapid advances in AI, many drug discovery models still struggle to translate computational predictions into clinical ...

A newly identified protein may explain why some failing hearts recover function following mechanical support while others do ...

Researchers at the Harrington Discovery Institute have identified cellular mechanisms involving Golgi apparatus proteins that ...